Narcolepsy.
Barateau L, Pizza F, Plazzi G, Dauvilliers Y.
J Sleep Res. 2022 Aug;31(4):e13631. doi: 10.1111/jsr.13631. Epub 2022 May 27.
Narcolepsies, update in 2023.
Barateau L, Pizza F, Chenini S, Peter-Derex L, Dauvilliers Y.
Rev Neurol (Paris). 2023 Oct;179(7):727-740. doi: 10.1016/j.neurol.2023.08.001. Epub 2023 Aug 25.
Cataplexy.
Reading P.
Pract Neurol. 2019 Feb;19(1):21-27. doi: 10.1136/practneurol-2018-002001. Epub 2018 Oct 24.
[Narcolepsy with cataplexy].
Dauvilliers Y, Arnulf I.
Rev Neurol (Paris). 2008 Aug-Sep;164(8-9):634-45. doi: 10.1016/j.neurol.2007.08.012. Epub 2008 Mar 4.
CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia.
Kanbayashi T, Inoue Y, Chiba S, Aizawa R, Saito Y, Tsukamoto H, Fujii Y, Nishino S, Shimizu T.
J Sleep Res. 2002 Mar;11(1):91-3. doi: 10.1046/j.1365-2869.2002.00284.x.
Challenges in diagnosing narcolepsy without cataplexy: a consensus statement.
Baumann CR, Mignot E, Lammers GJ, Overeem S, Arnulf I, Rye D, Dauvilliers Y, Honda M, Owens JA, Plazzi G, Scammell TE.
Sleep. 2014 Jun 1;37(6):1035-42. doi: 10.5665/sleep.3756.
Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls.
Nishino S, Sakurai E, Nevsimalova S, Yoshida Y, Watanabe T, Yanai K, Mignot E.
Sleep. 2009 Feb;32(2):175-80. doi: 10.1093/sleep/32.2.175.
[Narcolepsy].
Mayer G.
Nervenarzt. 2014 Jan;85(1):26, 28-34. doi: 10.1007/s00115-013-3889-2.
Sleep-wake stability in narcolepsy patients with normal, low and unmeasurable hypocretin levels.
Hansen MH, Kornum BR, Jennum P.
Sleep Med. 2017 Jun;34:1-6. doi: 10.1016/j.sleep.2017.01.021. Epub 2017 Mar 14.
Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
Oka Y, Inoue Y, Kanbayashi T, Kuroda K, Miyamoto M, Miyamoto T, Ikeda A, Shimizu T, Hishikawa Y, Shibasaki H.
Sleep. 2006 Nov;29(11):1439-43. doi: 10.1093/sleep/29.11.1439.
